Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 31,557
  • Shares Outstanding, K 420,755
  • Annual Sales, $ 41,961 K
  • Annual Income, $ -10,694 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.06
  • Price/Sales 0.68
  • Price/Cash Flow N/A
  • Price/Book 0.83
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 11/13/25
  • Next Earnings Date 03/26/25
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0600 +25.00%
on 12/11/25
0.0750 unch
on 12/19/25
+0.0100 (+15.38%)
since 11/19/25
3-Month
0.0600 +25.00%
on 12/11/25
0.0850 -11.76%
on 10/09/25
+0.0050 (+7.14%)
since 09/19/25
52-Week
0.0600 +25.00%
on 12/11/25
0.1200 -37.50%
on 03/24/25
+0.0100 (+15.38%)
since 12/19/24

Most Recent Stories

More News
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns

TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids,...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Completes First Shipment to France

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ MediPharm ” or the “ Company ”), a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains

Q3 2025 Revenue of $11.4 Million, an Increase of 17% over Q3 2024 83% Growth in Year-Over-Year Revenue for International Medical Cannabis International Medical sales now 56% of Total Revenue Increased...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders

TORONTO , May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (" MediPharm " or the " Company "), a pharmaceutical company specialized in precision-based cannabinoids, has filed...

LABS.TO : 0.0750 (+7.14%)
Stocks in play: MediPharm Labs Corp.

Today announced its financial results for the three months ended June 30, 2025. Q2 Revenue was $11.8 ...

LABS.TO : 0.0750 (+7.14%)
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis

Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Million...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States

TORONTO , Aug. 13, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops,...

See More

Key Turning Points

3rd Resistance Point 0.0817
2nd Resistance Point 0.0783
1st Resistance Point 0.0767
Last Price 0.0750
1st Support Level 0.0717
2nd Support Level 0.0683
3rd Support Level 0.0667

See More

52-Week High 0.1200
Fibonacci 61.8% 0.0971
Fibonacci 50% 0.0900
Fibonacci 38.2% 0.0829
Last Price 0.0750
52-Week Low 0.0600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar